166 related articles for article (PubMed ID: 25115612)
1. Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa.
Jovic S; Shikhagaie M; Mörgelin M; Kjellström S; Erjefalt J; Olin AI; Frick IM; Egesten A
J Innate Immun; 2014; 6(6):846-59. PubMed ID: 25115612
[TBL] [Abstract][Full Text] [Related]
2. The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.
Jovic S; Linge HM; Shikhagaie MM; Olin AI; Lannefors L; Erjefält JS; Mörgelin M; Egesten A
Mucosal Immunol; 2016 Jan; 9(1):112-23. PubMed ID: 25993443
[TBL] [Abstract][Full Text] [Related]
3. SufA of the opportunistic pathogen finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.
Karlsson C; Eliasson M; Olin AI; Mörgelin M; Karlsson A; Malmsten M; Egesten A; Frick IM
J Biol Chem; 2009 Oct; 284(43):29499-508. PubMed ID: 19628464
[TBL] [Abstract][Full Text] [Related]
4. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
6. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
Respir Med; 2020; 170():105994. PubMed ID: 32843162
[TBL] [Abstract][Full Text] [Related]
7. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
8. High expression of midkine in the airways of patients with cystic fibrosis.
Nordin SL; Jovic S; Kurut A; Andersson C; Gela A; Bjartell A; Mörgelin M; Olin AI; Lund M; Egesten A
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):935-42. PubMed ID: 23815177
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
[TBL] [Abstract][Full Text] [Related]
10. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
11. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
12. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
13. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.
Yoo DG; Winn M; Pang L; Moskowitz SM; Malech HL; Leto TL; Rada B
J Immunol; 2014 May; 192(10):4728-38. PubMed ID: 24740504
[TBL] [Abstract][Full Text] [Related]
14. Significance of immunologic factors in cystic fibrosis.
Przyklenk B; Bauernfeind A
Scand J Gastroenterol Suppl; 1988; 143():103-9. PubMed ID: 2455329
[TBL] [Abstract][Full Text] [Related]
15. Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect.
Linge HM; Sastalla I; Nitsche-Schmitz DP; Egesten A; Frick IM
Microbiology (Reading); 2007 Nov; 153(Pt 11):3800-3808. PubMed ID: 17975089
[TBL] [Abstract][Full Text] [Related]
16. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
[TBL] [Abstract][Full Text] [Related]
17. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
18. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
19. Citrullination of extracellular histone H3.1 reduces antibacterial activity and exacerbates its proteolytic degradation.
Tanner L; Bhongir RKV; Karlsson CAQ; Le S; Ljungberg JK; Andersson P; Andersson C; Malmström J; Egesten A; Single AB
J Cyst Fibros; 2021 Mar; 20(2):346-355. PubMed ID: 32727663
[TBL] [Abstract][Full Text] [Related]
20. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
